CARDIOVASCULAR OUTCOMES IN ADULTS WITH HYPERTENSION WITH EVENING VERSUS MORNING DOSING OF USUAL ANTIHYPERTENSIVES IN THE UK. THE TIME STUDY.

被引：0

作者：

MacDonald, Thomas MacLennal ^{[1
]}

Mackenzie, Isla Shelah ^{[1
]}

Rogers, Amy ^{[1
]}

Poulter, Neil R. ^{[8
]}

Williams, Bryan ^{[5
]}

Brown, Morris J. ^{[7
]}

Webb, David J. ^{[3
]}

Ford, Ian ^{[2
]}

Rorie, David ^{[1
]}

Grieve, Kerr ^{[4
]}

Pigazzani, Fillippo ^{[1
]}

Rothwell, Peter M. ^{[6
]}

Young, Robin ^{[2
]}

McConnachie, Alex ^{[2
]}

Lang, Chim C. ^{[1
]}

机构：

[1] Univ Dundee, Dundee, Scotland

[2] Univ Glasgow, Glasgow, Lanark, Scotland

[3] Univ Edinburgh, Edinburgh, Midlothian, Scotland

[4] Univ Aberdeen, Aberdeen, Scotland

[5] UCL, London, England

[6] Univ Oxford, Oxford, England

[7] Queen Mary Univ, London, England

[8] Imperial Coll, London, England

来源：

JOURNAL OF HYPERTENSION | 2023年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

S-28-1

引用

页码：E65 / E65

页数：1

共 7 条

[1] Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial
Mackenzie, Isla S.
Rogers, Amy
Poulter, Neil R.
Williams, Bryan
Brown, Morris J.
Webb, David J.
Ford, Ian
Rorie, David A.
Guthrie, Greg
Grieve, J. W. Kerr
Pigazzani, Filippo
Rothwell, Peter M.
Young, Robin
McConnachie, Alex
Struthers, Allan D.
Lang, Chim C.
MacDonald, Thomas M.
LANCET, 2022, 400 (10361): : 1417 - 1425
[2] Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes: the Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) study
Pigazzani, Filippo
Dyar, Kenneth A.
Morant, Steve V.
Vetter, Celine
Rogers, Amy
Flynn, Robert W. V.
Rorie, David A.
Mackenzie, Isla S.
Cappuccio, Francesco P.
Manfredini, Roberto
MacDonald, Thomas M.
ECLINICALMEDICINE, 2024, 72
[3] Morning versus evening dosing of desloratadine in seasonal allergic rhinitis: A randomized controlled study. [ISRCTN23032971]
Haye R.
Høye K.
Berg O.
Frønes S.
Ødegård T.
Clinical and Molecular Allergy, 3 (1)
[4] Methods of a large prospective, randomised, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) study
Rorie, David A.
Rogers, Amy
Mackenzie, Isla S.
Ford, Ian
Webb, David J.
Willams, Bryan
Brown, Morris
Poulter, Neil
Findlay, Evelyn
Saywood, Wendy
MacDonald, Thomas M.
BMJ OPEN, 2016, 6 (02):
[5] Home blood pressure monitors owned by participants in a large decentralised clinical trial in hypertension: the Treatment In Morning versus Evening (TIME) study
Thineskrishna Anbarasan
Amy Rogers
David A. Rorie
J. W. Kerr Grieve
Thomas M. MacDonald
Isla S. Mackenzie
Journal of Human Hypertension, 2022, 36 : 32 - 39
[6] Home blood pressure monitors owned by participants in a large decentralised clinical trial in hypertension: the Treatment In Morning versus Evening (TIME) study
Anbarasan, Thineskrishna
Rogers, Amy
Rorie, David A.
Kerr Grieve, J. W.
MacDonald, Thomas M.
Mackenzie, Isla S.
JOURNAL OF HUMAN HYPERTENSION, 2022, 36 (01) : 32 - 39
[7] Investigating the quality of longitudinal self-reported BP measurements in a large, online randomised trial in hypertension: the Treatment In Morning versus Evening (TIME) study
Vickneson, Keeran
Rogers, Amy
Rorie, David
MacDonald, Thomas
Mackenzie, Isla
JOURNAL OF HUMAN HYPERTENSION, 2020, 34

← 1 →